Scarica l'app Stockscreener
1.61
2.42%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AXDX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.65
Aprire:
$1.58
Volume 24 ore:
44,568
Relative Volume:
0.72
Capitalizzazione di mercato:
$40.57M
Reddito:
$12.00M
Utile/perdita netta:
$-63.23M
Rapporto P/E:
-0.2046
EPS:
-7.87
Flusso di cassa netto:
$-43.02M
1 W Prestazione:
-5.29%
1M Prestazione:
-14.36%
6M Prestazione:
+16.67%
1 anno Prestazione:
-64.85%
Intervallo 1D:
$1.58
$1.68
Intervallo di 1 settimana:
$1.58
$1.78
Portata 52W:
$0.73
$5.23
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Nome
Accelerate Diagnostics Inc
Settore
Industria
Telefono
303-863-8088
Indirizzo
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Confronta AXDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
1.61 | 40.57M | 12.00M | -63.23M | -43.02M | -7.87 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-09 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-10-08 | Iniziato | BTIG Research | Neutral |
| 2020-08-07 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-09-27 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Iniziato | Craig Hallum | Hold |
| 2017-12-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2017-07-12 | Ripresa | BTIG Research | Buy |
| 2016-03-24 | Iniziato | JP Morgan | Overweight |
| 2015-12-16 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Accelerate Diagnostics Inc Borsa (AXDX) Ultime notizie
Accelerate Diagnostics (NASDAQ:AXDX) Raised to “Hold” at StockNews.com - Defense World
Glox Therapeutics awarded grant to accelerate development of precision antibiotics - European Pharmaceutical Manufacturer
Microbial Identification Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031 - WhaTech
William Blair Has Bearish Estimate for AXDX FY2024 Earnings - Defense World
Armistice Capital, LLC's Strategic Acquisition in Accelerate Dia - GuruFocus.com
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2024 Earnings Call Transcript - Insider Monkey
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Accelerate Diagnostics: Q3 Earnings Snapshot - Houston Chronicle
Accelerate Diagnostics Reports Key Advances Amid Financial Challenges - TipRanks
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - StockTitan
Antimicrobial Susceptibility Testing Market is Expected to Soar in the Upcoming Years - openPR
Accelerate Diagnostics (NASDAQ:AXDX) Earns Sell Rating from Analysts at StockNews.com - Defense World
BeeKeeperAI, Topcon Healthcare Collaborating on Optical Diagnostics - MPO-mag
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies - PR Newswire
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
AXDXAccelerate Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - Kilgore News Herald
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Comparing Accelerate Diagnostics (NASDAQ:AXDX) & Advanced BioMedical Technologies (OTCMKTS:ABMT) - Defense World
Global study shows cefiderocol’s success in treating resistant infections - European Pharmaceutical Manufacturer
Antimicrobial Resistance Diagnostics Market to Witness an Outstanding Growth by 2032 - openPR
Antibiotic Sensitivity Testing Market Growth and Industry Overview - News in Assen
Accelerate Diagnostics (NASDAQ:AXDX) Research Coverage Started at StockNews.com - Defense World
Optical Imaging Market Size to Reach USD 5.61 Billion by 2033 | Straits Research - GlobeNewswire
Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution - PR Newswire
Saudi Arabia Diagnostic Imaging Market Will Accelerate Rapidly - openPR
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System - Yahoo Finance
FDA approves Accelerate Arc system to identify microbial infections - Medical Device Network
FDA clears new system for rapid sepsis identification By Investing.com - Investing.com Australia
FDA clears new system for rapid sepsis identification - Investing.com
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - StockTitan
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology - Business Wire
Short Interest in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Drops By 12.6% - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Stake Reduced by Armistice Capital LLC - Defense World
StockNews.com Initiates Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Italy Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
North America Antimicrobial Resistance Diagnostics Market Size & Outlook, 2030 - Grand View Research
PersonalAIze and Cube Forge Groundbreaking Partnership to - GlobeNewswire
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics - Yahoo Finance
Accelerate Diagnostics (NASDAQ:AXDX) Stock Crosses Above 200 Day Moving Average of $1.21 - Defense World
Veterinary Antimicrobial Susceptibility Testing Market: In-depth Analysis Of Market Trends, Technological A... - WhaTech
Blood Screening Market Advancements Highlighted by Size, Share, Growth Analysis, Business Insights And Fore... - WhaTech
Europe Point Of Care TB And Drug-resistant TB Testing Market | Report, 2030 - Grand View Research
North America Antibiotic Sensitivity Testing Market By Application - Third Eye News
RenovaroCube to Present Cutting-Edge Cancer Diagnostics - GlobeNewswire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine - Business Wire
Chlamydia Infection Diagnostics And Therapeutics Global Market 2024Latest Trends, Technological Advancem... - WhaTech
Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News
New Release of Ibex Medical Analytics AI-powered Platform to Accelerate Advancements in Cancer Diagnostics - Business Wire
Accelerate Diagnostics Inc Azioni (AXDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):